Yejin Yun Selected Research

Tinnitus

1/2020

Proteasome Activity in the Plasma as a Novel Biomarker in Mild Cognitive Impairment with Chronic Tinnitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yejin Yun Research Topics

Disease

3	Neoplasms (Cancer) 06/2024 - 01/2018
2	Hearing Loss (Hearing Impairment) 04/2024 - 12/2023
1	Autosomal Dominant 36 Deafness 12/2023
1	Deafness (Deaf Mutism) 01/2023
1	Starvation 01/2023
1	Insulin Resistance 01/2022
1	Cognitive Dysfunction 01/2020
1	Tinnitus 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020

Drug/Important Bio-Agent (IBA)

3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 06/2024 - 12/2023
1	LipidsIBA 12/2023
1	ATP dependent 26S protease (26S proteasome)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	HoloenzymesIBA 01/2023
1	MelatoninIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	EnzymesIBA 01/2020

Therapy/Procedure

1	Therapeutics 04/2024